Announcements Trials
Browse Landscape

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 6Observational 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Solid Tumor 3Lung Neoplasms 3Breast Neoplasms 3Glioma 2Uterine Cervical Neoplasms 1Thyroid Neoplasms 1Solid Tumors 1Oncologic Diseases 1Neurotoxicity Syndromes 1Melanoma 1Liver Cirrhosis 1Glioblastoma 1Fatigue 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Breast Neoplasms, Male 1

Interventions

Thyroidectomy 5Iodine-131 5Surgical Procedures, Operative 3selpercatinib 2lenvatinib 2anlotinib 2Ultrasonography 2Transurethral Resection of Prostate 2Sorafenib 2Molecular Diagnostic Techniques 2Interviews as Topic 2Focus Groups 2Biopsy, Fine-Needle 2trastuzumab deruxtecan 1trametinib 1pralsetinib 1pembrolizumab 1gallium Ga 68 dotatate 1dabrafenib 1Triiodothyronine 1Thyroxine 1Thyrotropin Alfa 1Surveys and Questionnaires 1Routinely Collected Health Data 1Radiotherapy, Adjuvant 1Quality of Life 1Patient Reported Outcome Measures 1Observation 1Nivolumab 1Minimally Invasive Surgical Procedures 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Thyroid Neoplasms × Fluorodeoxyglucose F18 × Clear all
NCT00373711 2022-06-21

Comparison of I-124 PET/CT, F-18 FDG PET/CT & I-123 Whole Body Scintigraphy for Recurrent Thyroid CA

Stanford University

Withdrawn
Head & Neck

Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡